Literature DB >> 8594344

Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase.

S F Le Grice1, C E Cameron, S J Benkovic.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8594344     DOI: 10.1016/0076-6879(95)62015-x

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  61 in total

1.  Solid-Phase Synthesis of 5'-O-β,γ-Methylenetriphosphate Derivatives of Nucleosides and Evaluation of Their Inhibitory Activity Against HIV-1 Reverse Transcriptase.

Authors:  Yousef Ahmadibeni; Chandravanu Dash; Stuart F J Le Grice; Keykavous Parang
Journal:  Tetrahedron Lett       Date:  2010-06-02       Impact factor: 2.415

2.  The HIV-1 Nef protein enhances the affinity of reverse transcriptase for RNA in vitro.

Authors:  Cécile Fournier; Jean-Claude Cortay; Caroline Carbonnelle; Chantal Ehresmann; Roland Marquet; Pierre Boulanger
Journal:  Virus Genes       Date:  2002-12       Impact factor: 2.332

3.  Structure-activity relationships in HIV-1 reverse transcriptase revealed by radiation target analysis.

Authors:  Nicolas Sluis-Cremer; Ellis Kempner; Michael A Parniak
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

4.  Stereo-selectivity of HIV-1 reverse transcriptase toward isomers of thymidine-5'-O-1-thiotriphosphate.

Authors:  Jessica Radzio; Nicolas Sluis-Cremer
Journal:  Protein Sci       Date:  2005-06-03       Impact factor: 6.725

5.  Radiation target analyses of DNA template/primer complexes.

Authors:  Nicolas Sluis-Cremer; Ellis S Kempner
Journal:  Biophys J       Date:  2006-03-13       Impact factor: 4.033

6.  Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses.

Authors:  Qing Xia; Jessica Radzio; Karen S Anderson; Nicolas Sluis-Cremer
Journal:  Protein Sci       Date:  2007-08       Impact factor: 6.725

7.  Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.

Authors:  Egor P Tchesnokov; Aleksandr Obikhod; Raymond F Schinazi; Matthias Götte
Journal:  J Biol Chem       Date:  2009-07-21       Impact factor: 5.157

8.  Synthesis of nucleoside 5'-O-alpha,beta-methylene-beta-triphosphates and evaluation of their potency towards inhibition of HIV-1 reverse transcriptase.

Authors:  Y Ahmadibeni; C Dash; M J Hanley; S F J Le Grice; H K Agarwal; K Parang
Journal:  Org Biomol Chem       Date:  2010-01-13       Impact factor: 3.876

9.  Monitoring the amplification of CATCH, a 3SR based cooperatively coupled isothermal amplification system, by fluorimetric methods.

Authors:  R Ehricht; T Kirner; T Ellinger; P Foerster; J S McCaskill
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

10.  Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine.

Authors:  Hong-Tao Xu; Susan P Colby-Germinario; Eugene L Asahchop; Maureen Oliveira; Matthew McCallum; Susan M Schader; Yingshan Han; Yudong Quan; Stefan G Sarafianos; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.